BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Job Trends

  Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies

  In partnership with the U.S. government, Evonik Industries is investing more than $200 million to build a lipid manufacturing facility in the United States.

  June 2, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Regeneron to Buy Sanofi’s Stake in Libtayo for $900M Upfront

  Regeneron Pharmaceuticals announced intentions to acquire Sanofi’s stake in a drug they developed together, Libtayo (cemiplimab).

  June 2, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Research Roundup: Gene Regulation and Longevity, Comparing COVID-19 Vaccines

  Top research stories, including gene regulation and longevity, a head-to-head comparison of COVID-19 vaccines, a newly discovered type of brain cell and more.

  June 2, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Outbreak Updates: Monkeypox Highlights Animal-to-Human Interface, Dogs Sniff Out COVID-19

  Monkeypox is not COVID-19, but both are viral diseases that are front-and-center in the world of public health and epidemiology. Here’s a look at the latest news on both outbreaks.

  June 2, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  New Month, New Collaborations: BMS, Sorrento & Others Announce New Alliances

  With June just getting started, BMS and Sorrento are making new connections. Read on for announcements of these collaborations.

  June 2, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Business

  Flagship’s Tessera Wins Services of Ex-AbbVie Exec Severino

  Tessera Therapeutics announced Thursday that ex-AbbVie executive Michael Severino, M.D. will take the helm of the young biotech.

  June 2, 2022

   · 

  2 min read

   · 

  Paul Besabella
• 

  Drug Development

  J&J and BMS Drugs Reduce COVID-19 Deaths in Moderate-to-Severe Population

  Bristol Myers Squibb’s Orencia and Johnson & Johnson’s Remicade improved survival rates for people hospitalized with COVID-19 according to a new report by the National Institutes of Health.

  June 2, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Safety Signal Leads Centessa to Discontinue Development of Lead Asset

  Centessa announced Thursday it is discontinuing the development of its lead asset, lixivaptan, for autosomal dominant polycystic kidney disease (ADPKD).

  June 2, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  BioSpace Movers & Shakers: Pfizer, Black Diamond, Rezolute, Transition Bio and More

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  June 2, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  Drug Development

  Numinus CEO: Psychedelic-assisted Psychotherapy Still Driven by Perceptions

  BioSpace spoke with Payton Nyquvest, co-founder and CEO of Numinus about changing perceptions around psychedelic-assisted psychotherapy and the company’s work in this space.

  June 2, 2022

   · 

  6 min read

   · 

  Gail Dutton